Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Harvard Business School
Colorcon
Boehringer Ingelheim
McKesson

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Claforan In Dextrose 5% In Plastic Container, and when can generic versions of Claforan In Dextrose 5% In Plastic Container launch?

Claforan In Dextrose 5% In Plastic Container is a drug marketed by Us Pharm Holdings and is included in one NDA.

The generic ingredient in CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER is cefotaxime sodium. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cefotaxime sodium profile page.

Summary for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharm Holdings CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-002 May 20, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Us Pharm Holdings CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-004 May 20, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Medtronic
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.